Bioventus Inc.
BVSNasdaqHealthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $568.1M | $573.3M | $512.3M | $512.1M | $430.9M | $321.2M |
| Operating income | $54.0M | −$15.2M | −$81.7M | −$167.2M | $12.1M | $21.2M |
| Net income | $22.7M | −$36.1M | −$156.2M | −$158.7M | $19.4M | $16.4M |
| Total assets | $683.6M | $728.0M | $810.9M | $1.37B | $1.23B | $494.5M |
| Total liabilities | $455.1M | $542.4M | $589.8M | $960.4M | $618.2M | $350.3M |
| Equity | $184.1M | $147.9M | $173.6M | $325.2M | $458.9M | — |
| EPS (diluted) | $0.33 | $-0.56 | $-2.49 | $-2.59 | $-0.15 | — |
| Shares out. | 68.9M | 64.5M | 62.6M | 61.4M | 45.5M | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 9.5%
- Net margin
- 4.0%
- Return on equity
- 12.3%
- Return on assets
- 3.3%
- Return on capital (ROCE)
- 10.3%
- Liabilities / assets
- 66.6%
- Debt / equity
- 2.47×
- Book value / share
- $2.67
- Revenue growth (YoY)
- −0.9%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 0.44distress
- Accruals / assets
- −7.6%clean
- Piotroski F-Score
- 8/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 1 warning● 3 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Revenue declined year-over-year
- Operating margin is positive
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 11, 2023
- NT 10-Kmissed a reporting deadline ↗Mar 16, 2023
- NT 10-Qmissed a reporting deadline ↗Nov 16, 2022
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Clinical trials
ClinicalTrials.gov · ongoing · next readout firstInterventional studies led by this company. “Readout” is the trial's primary-completion date — an estimate the sponsor reports, not a guarantee.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Nantahala Capital Management, LlcPassive (13G)Feb 13, 2026
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Singleton Mark LeonardOfficer — SVP & CFO | Apr 10, 2026 | Option exercise | 13,000 | $0.00 |
| Church Katrina JOfficer — SVP & Chief Compliance Officer | Apr 10, 2026 | Option exercise | 4,300 | $0.00 |
| D'Adamio AnthonyOfficer — SVP & General Counsel | Apr 10, 2026 | Option exercise | 9,925 | $0.00 |
| Singleton Mark LeonardOfficer — SVP & CFO | Mar 20, 2026 | Option exercise | 18,625 | $0.00 |
| Singleton Mark LeonardOfficer — SVP & CFO | Mar 13, 2026 | Option exercise | 13,500 | $0.00 |
| Church Katrina JOfficer — SVP & Chief Compliance Officer | Mar 13, 2026 | Option exercise | 3,455 | $0.00 |
| D'Adamio AnthonyOfficer — SVP & General Counsel | Mar 13, 2026 | Option exercise | 8,886 | $0.00 |
| Claypoole Robert EOfficer — President and CEO | Mar 13, 2026 | Option exercise | 33,500 | $0.00 |
| Mcmurry-Heath MichelleDirector | Mar 11, 2026 | Sell | 12,000 | $8.79 |
| Singleton Mark LeonardOfficer — SVP & CFO | Feb 15, 2026 | Option exercise | 20,153 | $0.00 |
| Church Katrina JOfficer — SVP & Chief Compliance Officer | Feb 15, 2026 | Option exercise | 4,375 | $0.00 |
| D'Adamio AnthonyOfficer — SVP & General Counsel | Feb 15, 2026 | Option exercise | 12,980 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 1.6M | 2.9 | +7.5% |
| Apr 30, 2026 | 1.5M | 3.4 | +8.7% |
| Apr 15, 2026 | 1.3M | 3.1 | -12.1% |
| Mar 31, 2026 | 1.5M | 3.0 | +7.7% |
| Mar 13, 2026 | 1.4M | 3.2 | -0.8% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Regulation FD disclosureMay 21, 2026
- Results of operationsMay 6, 2026
- Results of operationsMar 5, 2026
- Director / officer changeNov 17, 2025
- Results of operationsNov 4, 2025
- Results of operationsAug 6, 2025
- Entered a material agreement · New financial obligationAug 4, 2025
- Other material eventJul 31, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.